TD Asset Management’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
404,396
-28,746
| -7% | -$816K | 0.01% | 609 |
|
|
2025
Q1 | $12.8M | Buy |
433,142
+17,970
| +4% | +$530K | 0.01% | 586 |
|
|
2024
Q4 | $12.1M | Sell |
415,172
-19,800
| -5% | -$576K | 0.01% | 614 |
|
|
2024
Q3 | $18.4M | Sell |
434,972
-78,366
| -15% | -$3.32M | 0.02% | 526 |
|
|
2024
Q2 | $21M | Buy |
513,338
+300,054
| +141% | +$12.3M | 0.02% | 487 |
|
|
2024
Q1 | $5.44M | Sell |
213,284
-54,448
| -20% | -$1.39M | 0.01% | 756 |
|
|
2023
Q4 | $2.42M | Hold |
267,732
| – | – | ﹤0.01% | 944 |
|
|
2023
Q3 | $1.71M | Buy |
267,732
+133,866
| +100% | +$854K | ﹤0.01% | 1002 |
|
|
2023
Q2 | $1.48M | Sell |
133,866
-18,702
| -12% | -$207K | ﹤0.01% | 1036 |
|
|
2023
Q1 | $2.34M | Sell |
152,568
-11,847
| -7% | -$182K | ﹤0.01% | 936 |
|
|
2022
Q4 | $3.65M | Buy |
164,415
+31,144
| +23% | +$691K | ﹤0.01% | 824 |
|
|
2022
Q3 | $2.23M | Buy |
133,271
+800
| +0.6% | +$13.4K | ﹤0.01% | 970 |
|
|
2022
Q2 | $1.93M | Sell |
132,471
-10,615
| -7% | -$154K | ﹤0.01% | 1017 |
|
|
2022
Q1 | $2.64M | Sell |
143,086
-5,258
| -4% | -$97.1K | ﹤0.01% | 1001 |
|
|
2021
Q4 | $3.53M | Buy |
148,344
+44,769
| +43% | +$1.06M | ﹤0.01% | 970 |
|
|
2021
Q3 | $2.55M | Buy |
103,575
+75,627
| +271% | +$1.86M | ﹤0.01% | 1013 |
|
|
2021
Q2 | $540K | Hold |
27,948
| – | – | ﹤0.01% | 1373 |
|
|
2021
Q1 | $610K | Buy |
27,948
+4,739
| +20% | +$103K | ﹤0.01% | 1367 |
|
|
2020
Q4 | $592K | Buy |
23,209
+1,600
| +7% | +$40.8K | ﹤0.01% | 1302 |
|
|
2020
Q3 | $608K | Buy |
21,609
+1,300
| +6% | +$36.6K | ﹤0.01% | 1196 |
|
|
2020
Q2 | $574K | Buy |
+20,309
| New | +$574K | ﹤0.01% | 1183 |
|